國家衛生研究院 NHRI:Item 3990099045/5877
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 912956      Online Users : 1162
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5877


    Title: Estrogen up-regulates osteopontin expression and synergy with epidermal growth factor promote lung cancer cell migration
    Authors: Tsai, MF;Hsu, LH;Wu, CR;Hsieh, SC;Liu, KJ;Kao, SH
    Contributors: National Institute of Cancer Research
    Abstract: Background: Estrogen has been postulated to contribute to the development and progression of non-small cell lung cancer. It’s also recognized that osteopontin (OPN) plays an important role in tumor progression and metastasis. We explored the characteristics of estrogen, and investigated the connections between estrogen and OPN in lung cancer cells migration, including the signaling pathway involved. The separate and combined effect of Tamoxifen - an estrogen receptor (ER) antagonist, and Ge tinib - an epidermal growth factor receptor (EGFR) antagonist, on the cancer cell migration were also studied.Methods: A549 and PE089 lung cancer cell lines were used for in vitro studies. Pleural effusions from patients with lung adenocarcinoma were collected for the measuring of the estrogen and OPN concentrations as well as their impact on lung cancer cell lines.Results: ER- β is the predominant receptor type in lung cancer cell lines. Estrogen promoted cancer cell proliferation, migration, and matrix metalloproteinase 2 activity. Confocal microscopy and Western blotting revealed ER- βtranslocation out of mitochondria and mitochondrial swelling on the stimulation of estrogen. The mitochondrial respiratory complexes were attenuated. Estrogen induced OPN expression. Osteopontin promoted cancer cell migration through ανβ3 integrin binding. Estrogen and OPN concentrations were both elevated and positively correlated in the malignant pleural effusion from patients with lung adenocarcinoma. Estrogen and OPN affected cell migration through activation of MEK-ERK pathway, which is a common downstream pathway of EGFR activation. Synergistic effect of ER antagonist and EGFR antagonist on the inhibition of lung cancer cells migration was noted.Conclusion: Estrogen up-regulates OPN expression and synergy with epidermal growth factor which promote lung cancer cell migration. Estrogen, with its receptor and OPN, has the potential to be a prognosticator and a new therapeutic target in lung cancer. Understanding the receptors status of patients and tumor characteristics could help better direct the selection of targeted treatment.
    Date: 2011-06
    Relation: Journal of Thoracic Oncology. 2011 Jun;6(6):S1001-S1002.
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1556-0864&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000291769800146
    Appears in Collections:[Ko-Jiunn Liu] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    ISI000291769800146.pdf70KbAdobe PDF1484View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback